--- page 1 ---
3
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
SUMMARY
OFFER PRICE
• The final Offer Price has been determined at HK$20.60 per Offer Share (exclusive of
brokerage of 1%, SFC transaction levy of 0.0027%, the Stock Exchange trading fee of
0.00565% and AFRC transaction levy of 0.00015%).
NET PROCEEDS FROM THE GLOBAL OFFERING
• Based on the Offer Price of HK$20.60 per Offer Share, the net proceeds from the Global
Offering to be received by the Company, after deducting the estimated underwriting
commissions and other fees and expenses payable by the Company in connection with the
Global Offering, are estimated to be approximately HK$3,483.3 million. The Company
intends to apply such net proceeds from the Global Offering for the purposes and in the
amounts as set out in the section headed “Net Proceeds from the Global Offering ” in this
announcement.
• If the Over-allotment Option is exercised in full, the Company will receive additional
net proceeds of approximately HK$380.8 million for 19,158,500 additional Shares to be
issued and allotted upon the exercise of the Over-allotment Option after deducting the
estimated underwriting commissions and other fees and expenses payable by the Company
in connection with the Global Offering. The allocation of the additional net proceeds will
be adjusted on a pro rata basis according to the use of proceeds as set out in the section
headed “Net Proceeds from the Global Offering ” in this announcement in the event that the
Over-allotment Option is exercised.
APPLICATIONS AND INDICATIONS OF INTEREST RECEIVED
Hong Kong Public Offering
• The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have
been very significantly over-subscribed. At the close of the application lists at 12:00 noon
on Friday, November 10, 2023, a total of 30,726 valid applications have been received
under the Hong Kong Public Offering through the White Form eIPO service and the
CCASS EIPO service for a total of 891,591,500 Hong Kong Offer Shares, representing
approximately 49.96 times of the total number of 17,845,000 Offer Shares initially
available for subscription under the Hong Kong Public Offering.
• As the over-subscription in the Hong Kong Public Offering represents 15 times or more
but less than 50 times of the number of Hong Kong Offer Shares initially available under
the Hong Kong Public Offering, the reallocation procedure as described in the section
headed “Structure of the Global Offering – The Hong Kong Public Offering – Reallocation
and Clawback ” in the Prospectus has been applied and 35,689,000 Offer Shares have been
reallocated from the International Offering to the Hong Kong Public Offering. The final
number of Offer Shares under the Hong Kong Public Offering is 53,534,000 Offer Shares,
representing approximately 30% of the total number of Offer Shares initially available
under the Global Offering (before any exercise of the Over-allotment Option). The total
number of successful applicants under the Hong Kong Public Offering is 14,832, among
which 8,362 applicants were allocated with one board lot of the Offer Shares.


--- page 2 ---
4
Preferential Offering
• A total of four valid applications for Assured Entitlement and 15 valid applications for the excess
Reserved Shares (including 4 Qualifying WXB Shareholders who applied for excess Reserved
Shares in addition to their respective Assured Entitlement) pursuant to the Preferential Offering
from Qualifying WXB Shareholders on BLUE  Application Forms for a total of 95,640,715
Reserved Shares have been received, representing approximately 10.72 times the total number of
8,922,000 Reserved Shares initially available under the Preferential Offering. 8,922,000 Reserved
Shares were allocated to a total of 15 Qualifying WXB Shareholders, representing 5% of the total
number of Offer Shares initially available under the Global Offering (before any exercise of the
Over-allotment Option).
Allocation of Reserved Shares to Certain Directors and/or their Close Associates
• To the best knowledge of the Company and after all reasonable enquiries, among the
Reserved Shares allocated to the Qualifying WXB Shareholders, approximately 78,815
and 6 Reserved Shares, representing approximately 0.0067% and 0.0000% of the total
issued share capital of the Company immediately upon completion of the Global Offering
(assuming the Over-allotment Option is not exercised and without taking into account
any exercise of the share options granted under the Pre-IPO Share Option Schemes),
are expected to be allocated to our Directors Dr. Zhisheng Chen and Ms. Ming Shi (the
“Relevant Directors ”) and/or their close associates based on their respective applications
made by BLUE Application Forms, respectively, each of whom is a core connected person
of the Company.
• The Company has applied to the Stock Exchange for, and the Stock Exchange has granted,
a waiver from strict compliance with Rule 10.03 and Rule 9.09(b) of the Listing Rules
and a consent under Paragraph 5(2) of Appendix 6 to the Listing Rules (the “Placing
Guidelines ”) to permit the Company to allocate the Reserved Shares to the Relevant
Directors and/or their close associates in the Preferential Offering. Please refer to the
section headed “Waivers and Exemption from Strict Compliance with the Listing Rules and
the Companies (Winding Up and Miscellaneous Provisions) Ordinance ” in the Prospectus
and the section headed “Basis of Allocation under the Preferential Offering – Allocation of
Reserved Shares to Certain Directors and/or their Close Associates ” in this announcement.
International Offering
• The Offer Shares initially offered under the International Offering have been significantly
over-subscribed. A total of 3,147,738,952 International Offer Shares have been subscribed
(including the subscription by the Cornerstone Investors), representing approximately 19.60
times of the total number of 160,601,000 International Offer Shares initially available for
subscription under the International Offering (including 8,922,000 Reserved Shares under the
Preferential Offering). After reallocation of the Offer Shares to the Hong Kong Public Offering
from the International Offering, the final number of Offer Shares under the International
Offering is 124,912,000 Shares (including 8,922,000 Reserved Shares under the Preferential
Offering), representing approximately 70% of the total number of Offer Shares initially
available under the Global Offering (before any exercise of the Over-allotment Option).
• There has been an over-allocation of 19,158,500 Offer Shares in the International Offering
and there is a total of 170 placees under the International Offering. 67 placees have been
allotted five or fewer board lots of Offer Shares, representing approximately 39.4% of
the total number of placees under the International Offering. These placees have been
allotted 68,500 Offer Shares in total, representing approximately 0.043% of the Offer
Shares initially available under the International Offering and 0.038% of the Offer Shares
available under the Global Offering (both assuming the Over-allotment Option is not
exercised), respectively.


--- page 3 ---
5
Cornerstone Investors
• Based on the Offer Price of HK$20.60 per Offer Share (exclusive of brokerage of 1%,
SFC transaction levy of 0.0027%, the Stock Exchange trading fee of 0.00565% and AFRC
transaction levy of 0.00015%) and pursuant to the Cornerstone Investment Agreements as
disclosed in the section headed “Cornerstone Investors ” in the Prospectus, the Cornerstone
Investors will be allocated to a total of 113,910,000 Offer Shares, representing in aggregate
approximately (i) 63.83% of the Shares offered pursuant to the Global Offering and (ii)
9.67% of the total issued share capital of the Company immediately upon completion of
the Global Offering (without taking into account any Shares which may be issued upon
exercise of the share options granted under the Pre-IPO Share Option Schemes) (both
assuming the Over-allotment Option is not exercised), respectively. Please refer to the
section headed “International Offering – Cornerstone Investors ” in this announcement and
the section headed “Cornerstone Investors – The Cornerstone Investors ” in the Prospectus
for further details of the Cornerstone Investors.
Placing of Offer Shares to Connected Clients with Consent under the Placing Guidelines
• Under the International Offering, (i) 25,000 Offer Shares, representing approximately
0.0140% of the total number of Offer Shares initially available under the Global Offering
and 0.0021% of the total issued share capital of the Company immediately upon completion
of the Global Offering (without taking into account any Shares which may be issued upon
exercise of the share options granted under the Pre-IPO Share Option Schemes) (both
assuming the Over-allotment Option is not exercised), were placed to Goldman Sachs Asset
Management (Singapore) Pte. Ltd. ( “GSAMS”) as a placee who is a connected client of
Goldman Sachs (Asia) L.L.C. ( “GS”), one of the Overall Coordinators, within the meaning
of the Placing Guidelines; (ii) 760,000 Offer Shares, representing approximately 0.4259%
of the total number of Offer Shares initially available under the Global Offering and
0.0645% of the total issued share capital of the Company immediately upon completion
of the Global Offering (without taking into account any Shares which may be issued upon
exercise of the share options granted under the Pre-IPO Share Option Schemes) (both
assuming the Over-allotment Option is not exercised), were placed to China Southern Asset
Management Co., Ltd. (ʮ̡ ) ( “China Southern ”) as a placee who is a
connected client of Huatai Financial Holdings (Hong Kong) Limited ( “HTFH”), one of the
Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers, within the meaning
of the Placing Guidelines; and (iii) 40,000 Offer Shares, representing approximately
0.0224% of the total number of Offer Shares initially available under the Global Offering
and 0.0034% of the total issued share capital of the Company immediately upon completion
of the Global Offering (without taking into account any Shares which may be issued upon
exercise of the share options granted under the Pre-IPO Share Option Schemes) (both
assuming the Over-allotment Option is not exercised), were placed to Huatai Capital
Investment Limited ( “HTCI”) as a placee who is a connected client of HTFH within the
meaning of the Placing Guidelines. Other than HTCI, which holds the Offer Shares on a
non-discretionary basis on behalf of independent third parties for the purpose of hedging
the over-the-counter swaps transactions, GSAMS and China Southern hold the Offer Shares
on a discretionary basis on behalf of independent third parties.
• The Company has applied to the Stock Exchange for, and the Stock Exchange has granted
to the Company, its consent under paragraph 5(1) of the Placing Guidelines to permit the
Company to allocate Shares in the International Offering to GSAMS, China Southern and
HTCI. Offer Shares placed to the above connected clients are held by the connected clients
on behalf of independent third parties and are in compliance with all the conditions under
the consent granted by the Stock Exchange. Please refer to the section headed “International
Offering – Placing of Offer Shares to Connected Clients with Consent under the Placing
Guidelines ” in this announcement for further details.


--- page 4 ---
6
• Save as disclosed above, to the best knowledge, information and belief of the Directors,
(i) no Offer Shares placed by or through the Overall Coordinators, the Joint Global
Coordinators, the Joint Bookrunners, the Joint Lead Managers or the Underwriters under
the Global Offering have been placed with applicants and their respective ultimate
beneficial owners who are core connected persons (as defined in the Listing Rules) of
the Company, the Directors, or to any connected clients (as set out in paragraph 5(1) of
the Placing Guidelines) or persons set out in paragraph 5(2) of the Placing Guidelines,
whether in their own names or through nominees; (ii) none of the Joint Sponsors, the
Overall Coordinators, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead
Managers, the Underwriters and their respective affiliate companies, and the connected
clients of the lead broker or of any distributors (as defined in the Placing Guidelines)
has taken up any Offer Share for its own benefits under the Global Offering; and (iii) all
placees under the International Offering and their ultimate beneficial owners are not and
are independent of any of the (a) the core connected person (as defined in the Listing
Rules) of the Company, (b) the Directors or existing Shareholders of the Company or any
of the Company ’s subsidiaries, or (c) the close associates (as defined in the Listing Rules)
of (a) and/or (b) above, whether in their own names or through nominees. The International
Offering is in compliance with the Placing Guidelines.
• Save as disclosed in the sections headed “Basis of Allocation under the Preferential
Offering – Allocation of Reserved Shares to Certain Directors and/or their Close
Associates ” and “International Offering – Placing of Offer Shares to Connected Clients
with Consent under the Placing Guidelines ” of this announcement, the Directors, to the
best of their knowledge, information and belief, confirm that, (i) none of the Offer Shares
subscribed by public Shareholders in the Hong Kong Public Offering and placees in the
International Offering (including the Preferential Offering) has been financed directly
or indirectly by the Company, any of the Directors, chief executive, senior management,
the Controlling Shareholders, substantial Shareholders or existing Shareholders of the
Company or any of its subsidiaries or their respective close associates; (ii) no rebate has
been, directly or indirectly, provided by the Company, the Directors, chief executive, senior
management, the Controlling Shareholders, substantial Shareholders, existing Shareholders,
or any of their subsidiaries or their respective close associates, or syndicate members,
or any other brokers involved in the Global Offering, to any public Shareholders in the
Hong Kong Public Offering, Qualifying WXB Shareholders in the Preferential Offering
or placees in the International Offering; (iii) none of the public Shareholders in the Hong
Kong Public Offering and placees in the International Offering (including the Preferential
Offering) who has subscribed for the Offer Shares is accustomed to taking instructions from
the Company, any of the Directors, chief executive, senior management, the Controlling
Shareholders, substantial Shareholders or existing Shareholders of the Company or any of
its subsidiaries or their respective close associates in relation to the acquisition, disposal,
voting or other disposition of the Offer Shares registered in his/her/its name or otherwise
held by him/her/it; (iv) there is no side agreement or arrangement between the Company,
any of the Directors, chief executive, senior management, the Controlling Shareholders,
substantial Shareholders, existing Shareholders of the Company or any of its subsidiaries or
their respective close associates, on one hand, and the public subscribers or the placee who
has subscribed for the Offer Shares, on the other hand; and (v) the consideration payable
by the public investors in the Hong Kong Public Offering, Qualifying WXB Shareholders
in the Preferential Offering and placees in the International Offering for each Offer Share
subscribed for, or purchased by them, is the same as the Final Offer Price as determined by
the Company, plus brokerage of 1%, SFC transaction levy of 0.0027%, the Stock Exchange
trading fee of 0.00565% and AFRC transaction levy of 0.00015%.


--- page 5 ---
7
Over-allotment Option
• In connection with the Global Offering, the Company has granted the Over-allotment
Option to the International Underwriters exercisable by the Overall Coordinators (for
themselves and on behalf of the International Underwriters). Pursuant to the Over-allotment
Option, the International Underwriters have the right, exercisable by the Overall
Coordinators (for themselves and on behalf of the International Underwriters) at any time
from the Listing Date until Sunday December 10, 2023, being the 30th day after the last
day for lodging applications under the Hong Kong Public Offering, to require the Company
to issue and allot up to an aggregate of 19,158,500 additional Offer Shares, representing
approximately 10.74% of the number of Offer Shares initially available under the Global
Offering, at the Offer Price, to cover the over-allocations in the International Offering.
• There has been an over-allocation of 19,158,500 Offer Shares in the International
Offering and such over-allocation will be settled using Shares to be borrowed under the
Stock Borrowing Agreement entered into between WuXi Biologics and the Stabilizing
Manager. Such borrowed Shares will be covered by exercising the Over-allotment Option
in full or in part, or by making purchases in the secondary market by the Stabilization
Manager (or through its affiliates or any person acting for it) at prices that do not exceed
the Offer Price or by a combination of these means. In the event the Over-allotment
Option is exercised, an announcement will be made on the Stock Exchange ’s website at
www.hkexnews.hk  and the Company ’s website at www.wuxixdc.com . As at the date of
this announcement, the Over-allotment Option has not been exercised.
LOCK-UP OBLIGATIONS
• The Company, the Controlling Shareholders and the Cornerstone Investors are subject to
certain lock-up obligations as set out in the section headed “Lock-up Obligations ” in this
announcement.
RESULTS OF ALLOCATIONS
• The final offer price, the level of applications in the Hong Kong Public Offering, the level
of indication of interest in the International Offering and the Preferential Offering and
the basis of allocation of the Hong Kong Offer Shares and Reserved Shares are published
on the Stock Exchange ’s website at www.hkexnews.hk  and the Company ’s website at
www.wuxixdc.com  on Thursday, November 16, 2023.
• The results of allocations and the Hong Kong identity card/passport/Hong Kong business
registration/certificate of incorporation numbers of successful applicants under the Hong
Kong Public Offering and the Preferential Offering will be available at the times and dates
and in the manner specified below:
(i) in the announcement to be posted on the Stock Exchange ’s website at
www.hkexnews.hk  and the Company ’s website at www.wuxixdc.com  by no later
than 9:00 a.m. on Thursday, November 16, 2023;


--- page 6 ---
8
(ii) from the designated results of allocations website at www.iporesults.com.hk
(alternatively: English https://www.eipo.com.hk/en/Allotment ; Chinese
https://www.eipo.com.hk/zh-hk/Allotment ) with a “search by ID ” function from
8:00 a.m. on Thursday, November 16, 2023 to 12:00 midnight on Wednesday,
November 22, 2023; and
(iii) from the allocation results telephone enquiry line by calling +852 2862 8555 between
9:00 a.m. and 6:00 p.m. on Thursday, November 16, 2023, Friday, November 17,
2023, Monday, November 20, 2023, and Tuesday, November 21, 2023.
• This announcement contains a list of identification document numbers. Identification
document numbers shown in the section headed “Results of Applications Made by White
Form eIPO ” in this announcement refer to Hong Kong identity card numbers/passport
numbers/Hong Kong business registration numbers/certificate of incorporation numbers/
beneficial owner identification codes (if such applications are made by nominees as agent
for the benefit of another person) whereas those displayed in the section headed “Results
of Applications Made by Giving Electronic Application Instructions  to HKSCC via
CCASS” in this announcement are provided by CCASS Participants via CCASS. Therefore,
the identification document numbers shown in the two sections are different in nature.
• Please note that the list of identification document numbers set out in this announcement
may not be a complete list of successful applicants since only successful applicants whose
identification document numbers are provided to HKSCC by CCASS Participants are
disclosed. Applicants with beneficial names only but not identification document numbers
are not disclosed due to personal privacy issue as elaborated below. Applicants who applied
for the Hong Kong Offer Shares through their brokers can consult their brokers to enquire
about their application results.
• Since applications are subject to personal information collection statements, beneficial
owner identification codes displayed in the sections headed “Results of Applications Made
by White Form eIPO ”, “Results of Applications Made by BLUE Application Form ”
and “Results of Applications Made by Giving Electronic Application Instructions to
HKSCC via CCASS ” are redacted and not all details of applications are disclosed in this
announcement.
DISPATCH/COLLECTION OF SHARE CERTIFICATES/e -REFUND PAYMENT
INSTRUCTIONS/REFUND CHEQUES
• Applicants who have applied for (i) 1,000,000 or more Hong Kong Offer Shares through
the White Form eIPO service or (ii) 1,000,000 or more Reserved Shares on a BLUE
Application Form and whose application is wholly or partially successful may collect Share
certificate(s) or refund cheque(s) (where applicable) in person from the Hong Kong Share
Registrar, Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17/F
Hopewell Centre, 183 Queen ’s Road East, Wan Chai, Hong Kong, from 9:00 a.m. to 1:00
p.m. on Thursday, November 16, 2023, or any other place or date notified by the Company.


--- page 7 ---
9
• Applicants being an individual who is eligible for personal collection must not authorize
any other person to collect on their behalf. If you are a corporate applicant which is eligible
for personal collection, your authorized representative must bear a letter of authorization
from your corporation stamped with your corporation ’s chop. Both individuals and
authorized representatives must produce evidence of identity acceptable to the Hong Kong
Share Registrar of the Company at the time of collection.
• Applicants who apply for less than 1,000,000 Hong Kong Offer Shares through the
White Form eIPO service, will have their Share certificate(s) or refund cheque(s) (where
applicable) sent to the address specified in their application instructions on or before
Thursday, November 16, 2023 by ordinary post and at their own risk.
• Share certificates or refund cheques for Hong Kong Offer Shares allotted to applicants
who applied through the White Form eIPO service, or Reserved Shares who applied on
BLUE Application Forms, which are either not available for personal collection, or which
are available but are not collected in person within the time specified for collection, are
expected to be dispatched by ordinary post to those entitled to the addresses specified in
the relevant applications at their own risk on or before Thursday, November 16, 2023.
• Wholly or partially successful applicants who applied by giving electronic application
instructions to HKSCC will have their Share certificate(s) issued in the name of HKSCC
Nominees Limited and deposited directly into CCASS to be credited to their CCASS
Investor Participant stock accounts or the stock accounts of their designated CCASS
Participant who gave electronic application instructions on their behalf on Thursday,
November 16, 2023.
• Applicants who applied through a designated CCASS Participant (other than a CCASS
Investor Participant) should check the number of Hong Kong Offer Shares allocated to
them with that CCASS Participant.
• Applicants who applied as a CCASS Investor Participant by giving electronic application
instructions to HKSCC via CCASS may also check the number of Hong Kong Offer
Shares allocated to them and the amount of refund monies (if any) payable to them
via the CCASS Phone System and the CCASS Internet System (under the procedures
contained in HKSCC ’s “An Operating Guide for Investor Participants ” in effect from time
to time). Immediately after the crediting of the Hong Kong Offer Shares to the CCASS
Investor Participant stock accounts and the credit of refund monies to the CCASS Investor
Participants bank accounts, HKSCC will also make available to the CCASS Investor
Participants an activity statement showing the amount of Hong Kong Offer Shares credited
to their CCASS Investor Participant stock accounts and the refund amount credited to their
respective designated bank accounts (if any).
• For applicants who have applied for the Hong Kong Offer Shares through the White
Form eIPO service and paid the application monies through a single bank account, refund
monies (if any) will be dispatched to that bank account in the form of e-Refund payment
instructions. For applicants who have applied for the Hong Kong Offer Shares through
the White Form eIPO service and paid the application monies through multiple bank
accounts, refund monies (if any) will be dispatched to the addresses specified in your
application instructions in the form of refund cheque(s) in favor of the applicant (or, in the
case of joint applications, the first-named applicant) by ordinary post and at their own risk
on or before Thursday, November 16, 2023.


--- page 8 ---
10
• Refund monies (if any) for applicants who applied by giving electronic application
instructions to HKSCC via CCASS are expected to be credited to the relevant applicants ’
designated bank accounts or the designated bank accounts of their broker or custodian on
Thursday, November 16, 2023.
• Share certificates will only become valid at 8:00 a.m. on Friday, November 17, 2023,
provided that the Global Offering has become unconditional in all respects and neither the
Hong Kong Underwriting Agreement nor the International Underwriting Agreement has
been terminated in accordance with their respective terms at or before that time. Investors
who trade Shares on the basis of publicly available allocation details or prior to the receipt
of the Share certificates or prior to the Share certificates becoming valid do so entirely at
their own risk.
• No temporary document of title will be issued in respect of the Shares. No receipt will be
issued for sums paid on application.
PUBLIC FLOAT
• Immediately following completion of the Global Offering, assuming the Over-allotment
Option is not exercised, the number of Shares in public hands will represent approximately
15.14% of the total issued share capital of the Company (assuming the Over-allotment
Option is not exercised and without taking into account any exercise of the share options
granted under the Pre-IPO Share Option Schemes). The Company has applied to the Stock
Exchange for, and the Stock Exchange has granted to the Company, a waiver from strict
compliance with the requirements of Rule 8.08(1)(a) of the Listing Rules to exercise its
discretion subject to certain conditions under Rule 8.08(1)(d) of the Listing Rules.
• The Directors confirm that (a) no placee will, individually, be placed more than 10% of
the enlarged issued share capital of the Company immediately after the Global Offering;
(b) there will not be any new substantial Shareholder (as defined in the Listing Rules) of
the Company immediately after the Global Offering (assuming the Over-allotment Option
is not exercised and without taking into account any exercise of the share options granted
under the Pre-IPO Share Option Schemes); (c) the number of Offer Shares in public hands
will satisfy the minimum percentage as prescribed under the waiver granted by the Stock
Exchange from strict compliance with Rule 8.08(1)(a) of the Listing Rules; (d) the three
largest public Shareholders of the Company do not hold more than 50% of the Shares in
public hands at the time of Listing in compliance with Rules 8.08(3) and 8.24 of the Listing
Rules; and (e) there will be at least 300 Shareholders at the time of Listing in compliance
with Rule 8.08(2) of the Listing Rules.
COMMENCEMENT OF DEALINGS
• Assuming that the Global Offering becomes unconditional in all respects at or before 8:00
a.m. on Friday, November 17, 2023 (Hong Kong time), dealings in the Shares on the Main
Board of the Stock Exchange are expected to commence at 9:00 a.m. on Friday, November
17, 2023 (Hong Kong time). The Shares will be traded in board lots of 500 Shares each.
The stock code of the Shares is 2268.
In view of the high concentration of shareholding in a small number of Shareholders,
Shareholders and prospective investors should be aware that the price of the Shares could
move substantially even with a small number of Shares traded, and should exercise extreme
caution when dealing in the Shares.


--- page 9 ---
11
OFFER PRICE
The final Offer Price has been determined at HK$20.60 per Offer Share (exclusive of brokerage
of 1%, SFC transaction levy of 0.0027%, the Stock Exchange trading fee of 0.00565% and AFRC
transaction levy of 0.00015%).
NET PROCEEDS FROM THE GLOBAL OFFERING
Based on the Offer Price of HK$20.60 per Offer Share, the net proceeds from the Global Offering
to be received by the Company, after deducting the estimated underwriting commissions and other
fees and expenses payable by the Company in connection with the Global Offering, are estimated
to be approximately HK$3,483.3 million.
The Company intends to apply the net proceeds from the Global Offering as follows:
• approximately 67.0% of the net proceeds, or HK$2,333.8 million, will be used to further
expand our manufacturing capacity by (i) constructing our manufacturing facilities in
Singapore and (ii) expanding our production capacity in China with respect to antibody
intermediates;
• approximately 23.0% of the net proceeds, or HK$801.2 million, will be used to selectively
pursue strategic alliances, investment and acquisition opportunities primarily to enrich our
technology platform and service offerings and capabilities; and
• approximately 10.0% of the net proceeds, or HK$348.3 million, for working capital and other
general corporate purposes.
If the Over-allotment Option is exercised in full, the Company will receive additional net proceeds
of approximately HK$380.8 million for 19,158,500 additional Shares to be issued and allotted upon
the exercise of the Over-allotment Option after deducting the estimated underwriting commissions
and other fees and expenses payable by the Company in connection with the Global Offering. Any
additional proceeds received from the exercise of the Over-allotment Option will also be allocated
to the above purposes on a pro rata basis.
For further information, please refer to the section headed “Future Plans and Use of Proceeds ” in
the Prospectus.


--- page 10 ---
12
APPLICATIONS AND INDICATIONS OF INTEREST RECEIVED
Hong Kong Public Offering
The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been
very significantly over-subscribed. At the close of the application lists at 12:00 noon on Friday,
November 10, 2023, a total of 30,726 valid applications have been received under the Hong Kong
Public Offering through the White Form eIPO service and the CCASS EIPO service for a total
of 891,591,500 Hong Kong Offer Shares, representing approximately 49.96 times of the total
number of 17,845,000 Offer Shares initially available for subscription under the Hong Kong Public
Offering, among which:
• 29,771 valid applications in respect of a total of 210,279,000 Hong Kong Offer Shares
were for the Hong Kong Public Offering with an aggregate subscription amount, based
on the maximum Offer Price of HK$20.60 per Offer Share (excluding brokerage of 1%,
SFC transaction levy of 0.0027%, the Stock Exchange trading fee of 0.00565% and AFRC
transaction levy of 0.00015%), of HK$5.0 million or less, representing approximately 23.57
times of the 8,922,500 Shares initially available for allocation in Pool A of the Hong Kong
Public Offering; and
• 955 valid applications in respect of a total of 681,312,500 Hong Kong Offer Shares were
for the Hong Kong Public Offering with an aggregate subscription amount, based on the
maximum Offer Price of HK$20.60 per Offer Share (excluding brokerage of 1%, SFC
transaction levy of 0.0027%, the Stock Exchange trading fee of 0.00565% and AFRC
transaction levy of 0.00015%), of more than HK$5.0 million, representing approximately
76.36 times of the 8,922,500 Shares initially available for allocation in Pool B of the Hong
Kong Public Offering.
No application has been rejected due to dishonored payments. No application has been rejected
due to invalid application. 22 multiple or suspected multiple applications have been identified
and rejected. No application for more than 8,922,500 Hong Kong Offer Shares (being 50% of the
17,845,000 Hong Kong Offer Shares initially available under the Hong Kong Public Offering) has
been identified.
As the over-subscription in the Hong Kong Public Offering represents 15 times or more but less
than 50 times of the number of Hong Kong Offer Shares initially available under the Hong Kong
Public Offering, the reallocation procedure as described in the section headed “Structure of the
Global Offering – The Hong Kong Public Offering – Reallocation and Clawback ” in the Prospectus
has been applied and 35,689,000 Offer Shares have been reallocated from the International
Offering to the Hong Kong Public Offering.
As a result of such reallocation, the final number of Offer Shares under the Hong Kong Public
Offering is 53,534,000 Offer Shares, representing approximately 30% of the total number of Offer
Shares initially available under the Global Offering (before any exercise of the Over-allotment
Option). The total number of successful applicants under the Hong Kong Public Offering is 14,832,
among which 8,362 applicants were allocated with one board lot of the Offer Shares, representing
approximately 56.38% of the Shareholders who were allocated the Offer Shares under the Hong
Kong Public Offering, totaling 4,181,000 Shares (representing approximately 7.81% of the total
Offer Shares under the Hong Kong Public Offering).


--- page 11 ---
13
The Hong Kong Offer Shares offered in the Hong Kong Public Offering were conditionally
allocated on the basis set out in the section headed “Basis of Allocation under the Hong Kong
Public Offering ” below.
Preferential Offering
At the close of the application lists at 12:00 noon on Friday, November 10, 2023, a total of four
valid applications for Assured Entitlement and 15 valid applications for the excess Reserved Shares
(including 4 Qualifying WXB Shareholders who applied for excess Reserved Shares in addition to
their respective Assured Entitlement) pursuant to the Preferential Offering from Qualifying WXB
Shareholders on BLUE Application Forms for a total of 95,640,715 Reserved Shares have been
received, representing approximately 10.72 times the total number of 8,922,000 Reserved Shares
initially available under the Preferential Offering. 8,922,000 Reserved Shares were allocated to a
total of 15 Qualifying WXB Shareholders, representing 5% of the total number of Offer Shares
initially available under the Global Offering (before any exercise of the Over-allotment Option).
No application has been rejected due to bounced cheque or dishonored payments. No application
has been rejected due to invalid application. No multiple or suspected multiple application has
been identified and rejected.
The Reserved Shares offered in the Preferential Offering were conditionally allocated on the basis
set out in the section headed “Basis of Allocation under the Preferential Offering ” below.
International Offering
The Offer Shares initially offered under the International Offering have been significantly
over-subscribed. A total number of 3,147,738,952 International Offer Shares have been subscribed
(including the subscription by the Cornerstone Investors), representing approximately 19.60
times of the total number of 160,601,000 International Offer Shares initially available for
subscription under the International Offering (including 8,922,000 Reserved Shares under the
Preferential Offering). After reallocation of the Offer Shares to the Hong Kong Public Offering
from the International Offering, the final number of Offer Shares under the International Offering
is 124,912,000 Shares (including 8,922,000 Reserved Shares under the Preferential Offering),
representing approximately 70% of the total number of Offer Shares initially available under the
Global Offering (before any exercise of the Over-allotment Option).
There has been an over-allocation of 19,158,500 Offer Shares in the International Offering and
there are a total of 170 placees under the International Offering, among which:
(1) a total of 28 placees have been allotted one board lot of Offer Shares or less, representing
approximately 16.5% of 170 placees under the International Offering. These placees have
been allotted 14,000 Offer Shares in aggregate, representing approximately 0.009% and
0.011% of the Offer Shares initially available under the International Offering and available
under the final International Offer Shares (both assuming the Over-allotment Option is not
exercised), respectively;


--- page 12 ---
14
(2) a total of 51 placees have been allotted two board lots of Offer Shares or less, representing
approximately 30.0% of 170 placees under the International Offering. These placees have
been allotted 37,000 Offer Shares in aggregate, representing approximately 0.023% and
0.030% of the Offer Shares initially available under the International Offering and available
under the final International Offer Shares (both assuming the Over-allotment Option is not
exercised), respectively;
(3) a total of 52 placees have been allotted three board lots of Offer Shares or less, representing
approximately 30.6% of 170 placees under the International Offering. These placees have
been allotted 38,500 Offer Shares in aggregate, representing approximately 0.024% and
0.031% of the Offer Shares initially available under the International Offering and available
under the final International Offer Shares (both assuming the Over-allotment Option is not
exercised), respectively;
(4) a total of 67 placees have been allotted four board lots of Offer Shares or less, representing
approximately 39.4% of 170 placees under the International Offering. These placees have
been allotted 68,500 Offer Shares in aggregate, representing approximately 0.043% and
0.055% of the Offer Shares initially available under the International Offering and available
under the final International Offer Shares (both assuming the Over-allotment Option is not
exercised), respectively; and
(5) a total of 67 placees have been allotted five board lots of the Offer Shares or less,
representing approximately 39.4% of 170 placees under the International Offering. These
placees have been allotted 68,500 Offer Shares in aggregate, representing approximately
0.043% and 0.055% of the Offer Shares initially available under the International Offering
and available under the final International Offer Shares (both assuming the Over-allotment
Option is not exercised), respectively.
Cornerstone Investors
Based on the Offer Price of HK$20.60 per Offer Share (exclusive of brokerage of 1%, SFC
transaction levy of 0.0027%, the Stock Exchange trading fee of 0.00565% and AFRC transaction
levy of 0.00015%) and pursuant to the Cornerstone Investment Agreements as disclosed in the
section headed “Cornerstone Investors ” in the Prospectus, the Cornerstone Investors will be
allocated to a total of 113,910,000 Offer Shares, representing in aggregate approximately (i)
63.83% of the Shares offered pursuant to the Global Offering and (ii) 9.67% of the total issued
share capital of the Company immediately upon completion of the Global Offering (without taking
into account any Shares which may be issued upon exercise of the share options granted under
the Pre-IPO Share Option Schemes) (both assuming the Over-allotment Option is not exercised),
respectively.


--- page 13 ---
15
The number of Offer Shares subscribed for by the Cornerstone Investors is determined as set out
below:
Approximate % of total
number of Offer Shares
Approximate % of total
Shares in issue immediately
following the completion of
the Global Offering
Cornerstone Investor
Investment
Amount (1)
Number of
Offer Shares (2)
Assuming
the Over-
allotment
Option is not
exercised
Assuming
the Over-
allotment
Option is fully
exercised
Assuming
the Over-
allotment
Option is not
exercised
Assuming
the Over-
allotment
Option is fully
exercised
(in million) (approximate) (approximate) (approximate) (approximate)
Invesco Advisers, Inc. HK$782.2 37,970,000 21.28% 19.22% 3.22% 3.17%
General Atlantic
 Singapore SPV 64 Pte.
 Ltd. HK$391.1 18,985,000 10.64% 9.61% 1.61% 1.59%
Al-Rayyan Holding LLC HK$352.0 17,086,500 9.58% 8.65% 1.45% 1.43%
UBS Asset Management
 (Singapore) Ltd. HK$312.9 15,188,000 8.51% 7.69% 1.29% 1.27%
HongShan Funds HK$234.7 11,391,000 6.38% 5.76% 0.97% 0.95%
Novo Holdings A/S HK$195.5 9,492,500 5.32% 4.80% 0.81% 0.79%
Lake Bleu Funds HK$78.2 3,797,000 2.13% 1.92% 0.32% 0.32%
Total HK$2,346.6 113,910,000 63.83% 57.65% 9.67% 9.51%
Notes:
(1) Calculated based on the exchange rate set out in the section headed “Information about this Prospectus and the
Global Offering – Exchange Rate Conversion ” in the Prospectus.
(2) Rounded down to nearest whole board lot of 500 Shares. Calculated based on the final Offer Price of HK$20.60
per Offer Share, being the high-end of the indicative Offer Price range set out in the Prospectus.
(3) Any discrepancies in the tables above between the amounts identified as total amounts and the sum of the
amounts listed therein are due to rounding.
The Cornerstone Placing forms part of the International Offering, and the Cornerstone Investors
will not acquire any Offer Shares under the Global Offering other than pursuant to the Cornerstone
Investment Agreements. The Offer Shares subscribed by the Cornerstone Investors will rank pari
passu in all respects with the fully paid Shares in issue following the completion of the Global
Offering and will be listed on the Stock Exchange, and will be counted towards the public float of
the Company under Rule 8.08 of the Listing Rules.


--- page 14 ---
16
To our Company ’s best knowledge, other than (i) UBS Asset Management (Singapore) Ltd. (whose
ultimate holding company UBS Group AG is listed on the SIX Swiss Exchange (Ticker Symbol:
UBSG) and on the New York Stock Exchange (Ticker Symbol: UBS)) and (ii) Invesco Advisers,
Inc. (whose ultimate holding company Invesco Ltd. is listed on the New York Stock Exchange
(Ticker Symbol: IVZ)), none of the Cornerstone Investors or their respective controlling entity is
listed on any stock exchange. Each of the Cornerstone Investors has confirmed that all necessary
approvals have been obtained with respect to the Cornerstone Placing and that no specific approval
from any stock exchange (if relevant) or its shareholders is required for the relevant cornerstone
investment as each of them has general authority to invest.
To our Company ’s best knowledge, each of the Cornerstone Investors is (i) not accustomed
to taking instructions from our Company, our Directors, chief executive of our Company, our
Controlling Shareholders, substantial shareholders of our Company or existing Shareholders or any
of its subsidiaries or their respective close associates in relation to the acquisition, disposal, voting
or other disposition of the Shares registered in their name or otherwise held by them; (ii) not
financed directly or indirectly by us, our Directors, chief executive, our Controlling Shareholders,
substantial shareholders, existing Shareholders or any of its subsidiaries or their respective close
associates; and (iii) an independent third party of our Group, our connected persons and their
respective associates, and is not a connected person (as defined in the Listing Rules) of our Group
and an existing shareholder or a close associate of our Group.
Other than (a) Lake Bleu Innovation Healthcare Master Fund Limited and Lake Bleu Prime
Healthcare Master Fund Limited; and (b) HSG Growth VII Holdco, Ltd and HCHP Master Fund,
each of the Cornerstone Investors is an independent third party of the other Cornerstone Investors.
Further, immediately following the completion of the Global Offering, none of the Cornerstone
Investors will have any Board representation in the Company, nor will any of the Cornerstone
Investors become a substantial Shareholder (as defined in the Listing Rules) of the Company.
There will be no delayed delivery or deferred settlement of Offer Shares subscribed by the
Cornerstone Investors and the consideration will be settled by the Cornerstone Investors before the
Listing Date.
Each of the Cornerstone Investors has agreed that it will not, whether directly or indirectly, at
any time during the period of six months from the Listing Date (the “Lock-up Period ”), dispose
of any of the Offer Shares they have purchased pursuant to the relevant Cornerstone Investment
Agreements, save for certain limited circumstances, such as transfers to any of its wholly-owned
subsidiaries, who will be bound by the same obligations of such Cornerstone Investor, including
the Lock-up Period restriction.
Placing of Offer Shares to Connected Clients with Consent under the Placing Guidelines
Certain Offer Shares were placed to connected clients of the Joint Bookrunners and the
Underwriters (each a “Connected Underwriter ”) within the meaning of the Placing Guidelines.
Other than HTCI, which holds the Offer Shares on a non-discretionary basis on behalf of
independent third parties for the purpose of hedging the over-the-counter swaps transactions,
GSAMS and China Southern hold the Offer Shares on a discretionary basis on behalf of
independent third parties. Details of which are set out below:


--- page 15 ---
17
Connected Underwriter(s) Placee
Number of
Offer Shares
placed
Approximate
% of the Offer
Shares initially
available
under the
Global
Offering (1)
Approximate
% of total
Shares in issue
immediately
following the
completion of
the Global
Offering (2)
Relationship with
the Connected
Underwriter(s)
Goldman Sachs (Asia) L.L.C. Goldman Sachs Asset
Management (Singapore)
Pte. Ltd. (3)
25,000 0.0140% 0.0021% GSAMS is a member
of the same group of
companies as GS.
Huatai Financial Holdings
(Hong Kong) Limited
China Southern Asset
Management Co., Ltd.
(ʮ
̡)(4)
760,000 0.4259% 0.0645% Each of China Southern
and HTFH is a member
of the same group of
companies.
Huatai Financial Holdings
(Hong Kong) Limited
Huatai Capital Investment
Limited (5)
40,000 0.0224% 0.0034% HTCI is a member of
the same group of
companies as HTFH.
Notes:
(1) Assuming the Over-allotment Option is not exercised.
(2) Assuming the Over-allotment Option is not exercised and without taking into account any exercise of the share
options granted under the Pre-IPO Share Option Schemes.
(3) GSAMS will manage the Shares as the discretionary manager for and on behalf of independent third parties and
the Shares are held with the respective client ’s custodian.
(4) China Southern, a qualified domestic institutional investor as approved by the relevant PRC authority to conduct
asset management business, will hold the Shares as the independent agent and discretionary manager of certain
QDII funds.
(5) HTFH is a Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager in connection with the Global
Offering. Pursuant to an ISDA Agreement (the “ISDA Agreement ”) entered into between, HTCI and the
investors (the “Huatai Clients ”), HTCI, which intends to participate in the Global Offering as a placee, will
hold the beneficial interest of the Offer Shares on a non-discretionary basis as the single underlying holder
under Client TRS (as defined below) placed by and fully funded (i.e. with no financing provided by HTCI)
by the Huatai Clients, by which, HTCI will pass the full economic exposure of the Offer Shares to the Huatai
Clients, which in effect, HTCI will hold the beneficial interest of the Offer Shares on behalf of the Huatai
Clients. HTFH, a Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager of the Global Offering,
and HTCI are affiliated companies. Accordingly, HTCI is considered as a “connected client ” of HTFH pursuant
to paragraph 13(7) of the Placing Guidelines.
Instead of directly subscribing for the Offer Shares, the Huatai Clients will place a total return swap order (the
“Client TRS ”) with HTCI in connection with the Company ’s Global Offering. In order to hedge its exposure
under the Client TRS, HTCI participates in the Company ’s Global Offering and subscribes the Offer Shares
through placing order with HTFH during the International Offering.


--- page 16 ---
18
To the best of the knowledge and after making all reasonable enquiries, each of the Huatai Clients is an
independent third party of the Company and their respective associates.
The purpose of HTCI to subscribe for the Offer Shares is for hedging the Client TRS order placed by the Huatai
Clients. Pursuant to the terms of the contract of the Client TRS, during the tenor of the Client TRS, all economic
returns of the Offer Shares will be passed to the Huatai Clients through the Client TRS and all economic loss
shall be borne by the Huatai Clients. HTCI will not take any economic return or bear any economic loss in
relation to the Offer Shares.
The Huatai Clients may exercise an early termination right to terminate the Client TRS at any time from the
issue date of the Client TRS which should be on or after the date on which the Offer Shares are listed on the
Stock Exchange. Upon the termination upon maturity or early termination of the Client TRS by the Huatai
Clients, HTCI will dispose the Offer Shares on the secondary market and the Huatai Clients will receive a
final termination amount of the Client TRS which should have taken into account all the economic returns or
economic loss in relation to the Offer Shares. If upon the maturity of the Client TRS, the Huatai Clients intend
to extend the investment period, subject to further agreement between HTCI and the relevant Huatai Clients, the
term of the Client TRS could be extended by way of a new issuance or a tenor extension.
It is proposed that HTCI will hold the legal title and the voting right of the Offer Shares by itself, and pass
through the economic exposure to the Huatai Clients, each being a client who places a Client TRS order with
HTCI in connection with the Global Offering of the Company. Due to its internal policy, HTCI will not exercise
the voting right of the Offer Shares during the tenor of the Client TRS.
During the life of the Client TRS, HTCI may continue to hold the beneficial interest of the Offer Shares in its
custodian account, or to hold some or all of the Offer Shares in a prime brokerage account for stock borrowing
purposes (as further described in the paragraph below).
As permitted under the contractual arrangement with the Huatai Clients, HTCI will lend out its holding of
underlying Offer Shares in the form of stock borrowing loans consistent with market practice to lower its
finance costs, provided that HTCI has the ability to call back the Offer Shares on loan at any time in order to
satisfy its obligations under the Client TRS to ensure the economic interests to be passed to the Huatai Clients
will remain unchanged.
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted to the
Company, its consent under paragraph 5(1) of the Placing Guidelines to permit the Company to allocate
Shares in the International Offering to GSAMS, China Southern and HTCI. Offer Shares placed to the
above connected clients are held by the connected clients on behalf of independent third parties and are
in compliance with all the conditions under the consent granted by the Stock Exchange.
Save as disclosed above, to the best knowledge, information and belief of the Directors, (i) no
Offer Shares placed by or through the Overall Coordinators, the Joint Global Coordinators, the
Joint Bookrunners, the Joint Lead Managers or the Underwriters under the Global Offering have
been placed with applicants and their respective ultimate beneficial owners who are core connected
persons (as defined in the Listing Rules) of the Company, the Directors, or to any connected clients
(as set out in paragraph 5(1) of the Placing Guidelines) or persons set out in paragraph 5(2) of the
Placing Guidelines, whether in their own names or through nominees; (ii) none of the Joint Sponsors,
the Overall Coordinators, the Joint Global Coordinators, the Joint Bookrunners, the Joint Lead
Managers, the Underwriters and their respective affiliate companies, and the connected clients of the
lead broker or of any distributors (as defined in the Placing Guidelines) has taken up any Offer Share
for its own benefits under the Global Offering; and (iii) all placees under the International Offering
and their ultimate beneficial owners are not and are independent of any of the (a) the core connected
person (as defined in the Listing Rules) of the Company, (b) the Directors or existing Shareholders
of the Company or any of the Company ’s subsidiaries, or (c) the close associates (as defined in
the Listing Rules) of (a) and/or (b) above, whether in their own names or through nominees. The
International Offering is in compliance with the Placing Guidelines.


--- page 17 ---
19
Save as disclosed above, the Directors, to the best of their knowledge, information and belief,
confirm that, (i) none of the Offer Shares subscribed by public Shareholders in the Hong Kong
Public Offering and placees in the International Offering (including the Preferential Offering) has
been financed directly or indirectly by the Company, any of the Directors, chief executive, senior
management, the Controlling Shareholders, substantial Shareholders or existing Shareholders
of the Company or any of its subsidiaries or their respective close associates; (ii) no rebate has
been, directly or indirectly, provided by the Company, the Directors, chief executive, senior
management, the Controlling Shareholders, substantial Shareholders, existing Shareholders, or
any of their subsidiaries or their respective close associates, or syndicate members, or any other
brokers involved in the Global Offering, to any public Shareholders in the Hong Kong Public
Offering, Qualifying WXB Shareholders in the Preferential Offering or placees in the International
Offering; (iii) none of the public Shareholders in the Hong Kong Public Offering and placees
in the International Offering (including the Preferential Offering) who has subscribed for the
Offer Shares is accustomed to taking instructions from the Company, any of the Directors, chief
executive, senior management, the Controlling Shareholders, substantial Shareholders or existing
Shareholders of the Company or any of its subsidiaries or their respective close associates in
relation to the acquisition, disposal, voting or other disposition of the Offer Shares registered in
his/her/its name or otherwise held by him/her/it; (iv) there is no side agreement or arrangement
between the Company, any of the Directors, chief executive, senior management, the Controlling
Shareholders, substantial Shareholders, existing Shareholders of the Company or any of its
subsidiaries or their respective close associates, on one hand, and the public subscribers or the
placee who has subscribed for the Offer Shares, on the other hand; and (v) the consideration
payable by the public investors in the Hong Kong Public Offering, Qualifying WXB Shareholders
in the Preferential Offering and placees in the International Offering for each Offer Share
subscribed for, or purchased by them, is the same as the Final Offer Price as determined by the
Company, plus brokerage of 1%, SFC transaction levy of 0.0027%, the Stock Exchange trading fee
of 0.00565% and AFRC transaction levy of 0.00015%.
Over-allotment Option
In connection with the Global Offering, the Company has granted the Over-allotment Option to
the International Underwriters exercisable by the Overall Coordinators (for themselves and on
behalf of the International Underwriters). Pursuant to the Over-allotment Option, the International
Underwriters have the right, exercisable by the Overall Coordinators (for themselves and on behalf
of the International Underwriters) at any time from the Listing Date until Sunday December 10,
2023, being the 30th day after the last day for lodging applications under the Hong Kong Public
Offering, to require the Company to issue and allot up to an aggregate of 19,158,500 additional
Offer Shares, representing approximately 10.74% of the number of Offer Shares initially available
under the Global Offering, at the Offer Price, to cover the over-allocations in the International
Offering.
There has been an over-allocation of 19,158,500 Offer Shares in the International Offering and such
over-allocation will be settled using Shares to be borrowed under the Stock Borrowing Agreement
entered into between WuXi Biologics and the Stabilizing Manager. Such borrowed Shares will
be covered by exercising the Over-allotment Option in full or in part, or by making purchases
in the secondary market by the Stabilization Manager (or through its affiliates or any person
acting for it) at prices that do not exceed the Offer Price or by a combination of these means. In
the event the Over-allotment Option is exercised, an announcement will be made on the Stock
Exchange ’s website at www.hkexnews.hk  and the Company ’s website at www.wuxixdc.com .
As at the date of this announcement, the Over-allotment Option has not been exercised.


--- page 18 ---
20
LOCK-UP OBLIGATIONS
The Company, the Controlling Shareholders and the Cornerstone Investors are subject to certain
lock-up obligations (the “Lock-up Obligations ”) in respect of the Shares. The major terms of the
Lock-up Obligations are set out as follows:
Name
Number of Shares
subject to the
Lock-up
Obligations
Approximate %
of the total issued
share capital of the
Company following
the completion of the
Global Offering which
are subject to the
Lock-up Obligations
upon Listing (1)
Last day of the
Lock-up Period
The Company (2) (subject to lock-up obligations
pursuant to the Listing Rules and the Hong Kong
Underwriting Agreement)
N/A N/A May 16, 2024 (2)
Controlling Shareholders (3)
 WuXi AppTec (3) (subject to lock-up obligations
 pursuant to the Listing Rules)
400,000,000 33.94% May 16, 2024
(First Six-Month Period),
November 16, 2024
(Second Six-Month Period) (3)
 WuXi Biologics (4) (subject to lock-up
 obligations pursuant to the Listing Rules
 and obligations in favor of the Company
 pursuant to the Hong Kong Underwriting
 Agreement)
600,000,000 50.91% November 16,
2025 (Twenty Four-
Month Period) (4)
Cornerstone Investors (5) (subject to lock-up
obligations in favor of the Company pursuant to the
Cornerstone Investment Agreements)
113,910,000 9.67% May 16, 2024 (5)
Notes:
(1) Assuming the Over-allotment Option is not exercised and without taking into account any exercise of the share
options granted under the Pre-IPO Share Option Schemes.
(2) The Company may not issue or agree to issue or announce its intention to issue Shares or securities of the
Company on or before the indicated date unless in compliance with the requirements of the Listing Rules.
(3) For details of the lock-up obligations of the Controlling Shareholders, please refer to the sections headed
“Underwriting – Underwriting Arrangements and Expenses – Undertakings to the Stock Exchange pursuant to
the Listing Rules – Undertakings by our Controlling Shareholders ” in the Prospectus.
(4) For details of the lock-up obligations of WuXi Biologics, please refer to the sections headed “Underwriting –
Underwriting Arrangements and Expenses – Undertakings Pursuant to the Hong Kong Underwriting Agreement
– Undertakings by WuXi Biologics ” in the Prospectus.
(5) The Cornerstone Investors may not dispose of any of the Offer Shares subscribed pursuant to the relevant
Cornerstone Investment Agreements in the Global Offering prior to the indicated date, save for certain limited
circumstances, such as transfers to any of its wholly-owned subsidiaries, who will be bound by the same
obligations of such Cornerstone Investor, including the lock-up obligations.


--- page 19 ---
21
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the section headed “Structure of the Global
Offering – Conditions of the Global Offering ” in the Prospectus, 30,726 valid applications made
by the public through the White Form eIPO  service and the CCASS EIPO  service will be
conditionally allocated on the basis set out below:
NO. OF SHARES
APPLIED FOR
NO. OF VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTTED OF
THE TOTAL NO.
OF SHARES
APPLIED FOR
POOL A
500 12,488 1,623 out of 12,488 to receive 500 Shares 13.00%
1,000 1,887 490 out of 1,887 to receive 500 Shares 12.98%
1,500 896 349 out of 896 to receive 500 Shares 12.98%
2,000 5,476 2,843 out of 5,476 to receive 500 Shares 12.98%
2,500 996 646 out of 996 to receive 500 Shares 12.97%
3,000 357 277 out of 357 to receive 500 Shares 12.93%
3,500 226 204 out of 226 to receive 500 Shares 12.90%
4,000 514 500 Shares plus 16 out of 514 to receive additional 500 Shares 12.89%
4,500 436 500 Shares plus 69 out of 436 to receive additional 500 Shares 12.87%
5,000 1,277 500 Shares plus 366 out of 1,277 to receive additional 500 Shares 12.87%
6,000 259 500 Shares plus 141 out of 259 to receive additional 500 Shares 12.87%
7,000 180 500 Shares plus 144 out of 180 to receive additional 500 Shares 12.86%
8,000 178 1,000 Shares plus 10 out of 178 to receive additional 500 Shares 12.85%
9,000 1,181 1,000 Shares plus 370 out of 1,181 to receive additional 500 Shares 12.85%
10,000 805 1,000 Shares plus 459 out of 805 to receive additional 500 Shares 12.85%
15,000 417 1,500 Shares plus 357 out of 417 to receive additional 500 Shares 12.85%
20,000 339 2,500 Shares plus 47 out of 339 to receive additional 500 Shares 12.85%
25,000 235 3,000 Shares plus 100 out of 235 to receive additional 500 Shares 12.85%
30,000 183 3,500 Shares plus 130 out of 183 to receive additional 500 Shares 12.85%
35,000 116 4,000 Shares plus 115 out of 116 to receive additional 500 Shares 12.84%
40,000 113 5,000 Shares plus 31 out of 113 to receive additional 500 Shares 12.84%
45,000 102 5,500 Shares plus 57 out of 102 to receive additional 500 Shares 12.84%
50,000 285 6,000 Shares plus 237 out of 285 to receive additional 500 Shares 12.83%
60,000 107 7,500 Shares plus 27 out of 107 to receive additional 500 Shares 12.71%
70,000 73 8,500 Shares plus 55 out of 73 to receive additional 500 Shares 12.68%
80,000 75 10,000 Shares plus 22 out of 75 to receive additional 500 Shares 12.68%
90,000 37 11,000 Shares plus 30 out of 37 to receive additional 500 Shares 12.67%
100,000 188 12,500 Shares plus 64 out of 188 to receive additional 500 Shares 12.67%
125,000 83 15,500 Shares plus 56 out of 83 to receive additional 500 Shares 12.67%
150,000 77 19,000 Shares plus 1 out of 77 to receive additional 500 Shares 12.67%
175,000 34 22,000 Shares plus 12 out of 34 to receive additional 500 Shares 12.67%
200,000 46 25,000 Shares plus 31 out of 46 to receive additional 500 Shares 12.67%
225,000 105 27,000 Shares plus 99 out of 105 to receive additional 500 Shares 12.21%
29,771 Total number of Pool A successful applicants: 13,877


--- page 20 ---
22
NO. OF SHARES
APPLIED FOR
NO. OF VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTTED OF
THE TOTAL NO.
OF SHARES
APPLIED FOR
POOL B
250,000 669 27,500 Shares plus 138 out of 669 to receive additional 500 Shares 11.04%
500,000 104 28,000 Shares 5.60%
750,000 48 28,500 Shares 3.80%
1,000,000 61 29,000 Shares 2.90%
2,000,000 28 29,500 Shares 1.48%
3,000,000 8 30,000 Shares 1.00%
4,000,000 3 30,500 Shares 0.76%
5,000,000 5 31,000 Shares 0.62%
6,000,000 3 31,500 Shares 0.53%
7,000,000 1 32,000 Shares 0.46%
8,922,500 25 32,500 Shares 0.36%
955 Total number of Pool B successful applicants: 955
The final number of Offer Shares under the Hong Kong Public Offering is 53,534,000 Offer
Shares, representing approximately 30% of the total number of Offer Shares initially available
under the Global Offering (before any exercise of the Over-allotment Option).
BASIS OF ALLOCATION UNDER THE PREFERENTIAL OFFERING
The final number of Reserved Shares allocated to Qualifying WXB Shareholders in the Preferential
Offering is 8,922,000 Reserved Shares, representing approximately 5% of the Offer Shares initially
available under the Global Offering (before any exercise of the Over-allotment Option). Such
8,922,000 Reserved Shares have been allocated to a total of 15 Qualifying WXB Shareholders.
Among the Reserved Shares allocated, four valid applications in respect of a total of 1,598,043
Reserved Shares will be allocated to Qualifying WXB Shareholders as their Assured Entitlement
and 15 valid applications in respect of a total of 7,323,957 Reserved Shares will be allocated to
Qualifying WXB Shareholders under their valid applications for excess Reserved Shares.
No preferential treatment was given to any of the Qualifying WXB Shareholders in the allocation
of the Reserved Shares applied for by them under the Preferential Offering and such allocation of
Reserved Shares under the Preferential Offering was made in accordance with the allocation basis
disclosed in the section headed “Structure of the Global Offering – The Preferential Offering –
Basis of Allocation for Applications for the Reserved Shares ” in the Prospectus. Valid applications
made by Qualifying WXB Shareholders for excess Reserved Shares on BLUE Application Forms
will be conditionally allotted on the basis set out below:


--- page 21 ---
23
Preferential Offering
NO. OF
SHARES
APPLIED FOR
NO. OF
APPLICATIONS
TOTAL NO.
OF EXCESS
RESERVED
SHARES
APPLIED FOR
BASIS OF
ALLOTMENT/BALLOT
TOTAL NO.
OF RESERVED
SHARES
ALLOTED
APPROXIMATE
PERCENTAGE
OF ALLOCATION
BASED ON THE
THE TOTAL
NO. OF EXCESS
RESERVED
SHARES APPLIED
FOR IN THIS
CATEGORY
5 to 80,000 14 203,015 Allot Excess Reserved Shares applied for in
full
203,015 100.00%
93,839,657 1 93,839,657 Approximately 7.59% of the Excess
Reserved Shares applied for (HKSCC
Nominees Limited apply on behalf of the
applicants who apply in CCASS indirectly
through a broker/custodian)
7,120,942 7.59%
Total 15 94,042,672 7,323,957
Allocation of Reserved Shares to Certain Directors and/or their Close Associates
To the best knowledge of the Company and after all reasonable enquiries, among the Reserved
Shares allocated to the Qualifying WXB Shareholders, approximately 78,815 and 6 Reserved
Shares, representing approximately 0.0067% and 0.0000% of the total issued share capital of the
Company immediately upon completion of the Global Offering (assuming the Over-allotment
Option is not exercised and without taking into account any exercise of the share options
granted under the Pre-IPO Share Option Schemes), are expected to be allocated to our Directors
Dr. Zhisheng Chen and Ms. Ming Shi and/or their close associates based on their respective
applications made by BLUE Application Forms, respectively, each of whom is a core connected
person of the Company.
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a
waiver from strict compliance with Rule 10.03 and Rule 9.09(b) of the Listing Rules and a consent
under Paragraph 5(2) of the Placing Guidelines to permit the Company to allocate the Reserved
Shares to the Relevant Directors and/or their close associates in the Preferential Offering, subject
to the conditions disclosed in the section headed “Waivers and Exemption from Strict Compliance
with the Listing Rules and the Companies (Winding Up and Miscellaneous Provisions) Ordinance
– Waiver and Consent in respect to Allocation of Shares to Directors and their Close Associates in
Preferential Offering ” in the Prospectus. Such conditions have been satisfied.


--- page 22 ---
24
RESULTS OF ALLOCATIONS
The final offer price, the level of applications in the Hong Kong Public Offering, the level of
indication of interest in the International Offering and the Preferential Offering and the basis
of allocation of the Hong Kong Offer Shares and Reserved Shares are published on the Stock
Exchange ’s website at www.hkexnews.hk  and the Company ’s website at www.wuxixdc.com  on
Thursday, November 16, 2023.
The results of allocations and the Hong Kong identity card/passport/Hong Kong business
registration/certificate of incorporation numbers of successful applicants under the Hong Kong
Public Offering and the Preferential Offering will be available at the times and dates and in the
manner specified below:
(i) in the announcement to be posted on the Stock Exchange ’s website at www.hkexnews.hk
and the Company ’s website at www.wuxixdc.com  by no later than 9:00 a.m. on Thursday,
November 16, 2023;
(ii) from the designated results of allocations website at www.iporesults.com.hk  (alternatively: English
https://www.eipo.com.hk/en/Allotment ; Chinese https://www.eipo.com.hk/zh-hk/Allotment)
with a “search by ID” function from 8:00 a.m. on Thursday, November 16, 2023 to 12:00 midnight
on Wednesday, November 22, 2023; and
(iii) from the allocation results telephone enquiry line by calling +852 2862 8555 between 9:00
a.m. and 6:00 p.m. on Thursday, November 16, 2023, Friday, November 17, 2023, Monday,
November 20, 2023, and Tuesday, November 21, 2023.
This announcement contains a list of identification document numbers. Identification document
numbers shown in the section headed “Results of Applications Made by White Form eIPO ” in this
announcement refer to Hong Kong identity card numbers/passport numbers/Hong Kong business
registration numbers/certificate of incorporation numbers/beneficial owner identification codes (if
such applications are made by nominees as agent for the benefit of another person) whereas those
displayed in the section headed “Results of Applications Made by Giving Electronic Application
Instructions to HKSCC via CCASS ” in this announcement are provided by CCASS Participants
via CCASS. Therefore, the identification document numbers shown in the two sections are
different in nature.
Please note that the list of identification document numbers set out in this announcement may not
be a complete list of successful applicants since only successful applicants whose identification
document numbers are provided to HKSCC by CCASS Participants are disclosed. Applicants with
beneficial names only but not identification document numbers are not disclosed due to personal
privacy issue as elaborated below. Applicants who applied for the Hong Kong Offer Shares
through their brokers can consult their brokers to enquire about their application results.
Since applications are subject to personal information collection statements, beneficial owner
identification codes displayed in the sections headed “Results of Applications Made by White
Form eIPO ”, “Results of Applications Made by BLUE Application Form ” and “Results of
Applications Made by Giving Electronic Application Instructions to HKSCC via CCASS ” are
redacted and not all details of applications are disclosed in this announcement.


--- page 23 ---
25
SHAREHOLDING CONCENTRATION ANALYSIS
A summary of allotment results under the International Offering is set out below:
• Top 1, 5, 10, 20 and 25 placees under the International Offering (based on final number of
Offer Shares allocated to the placees under the International Offering after reallocation):
Assuming the Over-Allotment
Option is not exercised
Assuming the Over-Allotment
Option is fully exercised
Placee
Number of
International
Offer Shares
subscribed for
Total
Number of
Shares held
upon Listing
Subscription
as
approximate
% of the
International
Offering
Subscription
as
approximate
% of the
total Offer
Shares
Subscription
as
approximate
% of the
total issued
Shares upon
Listing
Subscription
as
approximate
% of the
International
Offering
Subscription
as
approximate
% of the
total Offer
Shares
Subscription
as
approximate
% of the
 total issued
Shares upon
Listing
Top 1 37,970,000 37,970,000 30.40% 21.28% 3.22% 26.36% 19.22% 3.17%
Top 5 100,620,500 100,620,500 80.55% 56.39% 8.54% 69.84% 50.92% 8.40%
Top 10 123,310,000 123,310,000 98.72% 69.10% 10.46% 85.59% 62.40% 10.30%
Top 20 130,524,000 130,524,000 104.49% 73.14% 11.08% 90.60% 66.05% 10.90%
Top 25 131,702,000 131,702,000 105.44% 73.80% 11.18% 91.41% 66.65% 11.00%
• Top 1, 5, 10, 20 and 25 Shareholders of all the Shareholders upon Listing (based on final
number of Offer Shares allocated to the placees under the International Offering after
reallocation):
Assuming the Over-Allotment
Option is not exercised
Assuming the Over-Allotment
Option is fully exercised
Shareholder
Number of
Hong Kong
Offer Shares
subscribed
for
Number of
International
Offer Shares
subscribed
for
Number of
Offer Shares
subscribed for
Total
Number of
Shares held
upon Listing
Number of
Shares
subscribed
for as
approximate
% of the
International
Offering
Number of
Shares
subscribed
for as
approximate
% of the
total Offer
Shares
Number of
Shares
held as
% of
total
issued
Shares
upon
Listing (1)
Number of
Shares
subscribed
for as
approximate
% of the
International
Offering
Number of
Shares
subscribed
for as
approximate
% of the
total Offer
Shares
Number of
Shares
held as
% of
total
issued
Shares
upon
Listing (1)
Top 1 – – – 600,000,000 – – 50.91% – – 50.10%
Top 5 – 74,041,500 74,041,500 1,074,041,500 59.27% 41.49% 91.14% 51.39% 37.47% 89.68%
Top 10 – 119,110,000 119,110,000 1,119,110,000 95.36% 66.75% 94.96% 82.67% 60.28% 93.45%
Top 20 – 129,992,000 129,992,000 1,129,992,000 104.07% 72.85% 95.89% 90.23% 65.78% 94.35%
Top 25 – 131,322,000 131,322,000 1,131,322,000 105.13% 73.59% 96.00% 91.15% 66.46% 94.47%
Note:
(1) Without taking into account any Shares which may be issued upon exercise of the share options granted under
the Pre-IPO Share Option Schemes.


--- page 24 ---
26
In view of the high concentration of shareholding in a small number of Shareholders,
Shareholders and prospective investors should be aware that the price of the Shares could
move substantially even with a small number of Shares traded, and should exercise extreme
caution when dealing in the Shares.
